Dimer Health, a clinician-led, AI-native transitional care medicine company, has raised $13.5 million in series A financing to expand its post-discharge care platform and accelerate national growth. The round was led by Team8 and Table Management, with participation from Silver Circle and TechAviv, bringing the company’s total funding to nearly $20 million.
The funding will support the expansion of Dimer Health’s dedicated clinical service line focused on the critical period following hospital discharge, a phase that remains largely underserved despite advancements in hospital care. Nearly half of hospital readmissions occur within the first 14 days after discharge, contributing to an estimated $52 billion to $62 billion in annual costs across the U.S. healthcare system.
Founded in 2023 and headquartered in Florham Park, New Jersey, Dimer Health is building a new care model designed specifically for the post-discharge window. The company combines an AI-powered patient engagement system with a physician-led transitional care practice to provide continuous oversight during recovery at home.
At the core of the platform is AiME, a proprietary clinical AI system developed by clinicians and grounded in physician-validated protocols. AiME engages patients in real time, analyzes symptoms in the context of medical history and medications, and detects early risk signals. When intervention is needed, patients are escalated to a licensed clinician known as a Transitionist, who manages care from discharge through recovery.
This model extends beyond traditional telehealth by offering structured, accountable oversight during a patient’s most vulnerable period. Each Transitionist is responsible for the full episode of care, ensuring continuity and proactive intervention.
Dimer Health has already demonstrated strong traction, operating across eight states with partnerships spanning 28 healthcare facilities and a regional payor. The company reports up to a 67% reduction in unnecessary readmissions, a net promoter score above 90, and 30% quarter-over-quarter revenue growth over four consecutive quarters.
The newly raised capital will be used to expand the Transitionist model, enhance AiME’s predictive capabilities and workflow automation, deepen partnerships with health systems and payors, and modernize legacy discharge processes to better align with patient-centered care expectations.
KEY QUOTES:
“The hospitalist did not exist before 1996. Today there are more than 60,000. That specialty emerged because outcomes were proven and the system adapted. The Transitionist is next.”
Caroline Hodge, PA-C, MS, MBA, CEO And Co-Founder, Dimer Health
“Some of healthcare’s biggest failures happen in the days after patients leave the hospital. Dimer Health is addressing that gap with a clinically rigorous, AI-enabled model that improves outcomes when patients are most vulnerable. We invested because Dimer is building the infrastructure for post-discharge care, and the team has already validated the model through disciplined execution and measurable impact.”
Sarit Firon, Managing Partner, Team8
